Pieris is a biotechnology company based in Boston, Massachusetts that could potentially be entitled to receive development, regulatory, and sales-based milestones from its 4-1BB bispecifics immuno-oncology assets partnered with Pfizer (formerly Seagen), Boston Pharmaceuticals, and Servier. In addition to the milestone potential, Pieris would be eligible for sales royalties on the same partnered programs if they ultimately are approved for commercialization. The Company is seeking potential acquirers for its remaining preclinical and clinical assets. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS. For more information, visit www.pieris.com.
View Top Employees from Pieris PharmaceuticalsWebsite | http://www.pieris.com/ |
Ticker | PIRS |
Revenue | $46 million |
Employees | 117 (117 on RocketReach) |
Founded | 2001 |
Address | 225 Franklin Street, Boston, Massachusetts 02110, US |
Phone | (857) 246-8998 |
Technologies |
JavaScript,
HTML,
Twitter
+16 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Biopharma, Drug Discovery, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 5 Million |
Keywords | Pieris Biotech, Pieris Pharmaceuticals, Pieris, Spring Works Therapeutics, Pieris Pharmaceuticals Inc. |
Competitors | Alkahest, Inc., Ambrx, GlycoMimetics, Mimetogen Pharmaceuticals Inc., Xenon Pharmaceuticals Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Pieris Pharmaceuticals employee's phone or email?
The Pieris Pharmaceuticals annual revenue was $46 million in 2024.
117 people are employed at Pieris Pharmaceuticals.
Pieris Pharmaceuticals is based in Boston, Massachusetts.
The NAICS codes for Pieris Pharmaceuticals are [325, 3254, 325414, 32, 32541].
The SIC codes for Pieris Pharmaceuticals are [283, 28].